Effect of CPAP treatment on BP in resistant hypertensive patients according to the BP dipping pattern and the presence of nocturnal hypertension

Nenhuma Miniatura disponível
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGERNATURE
Autores
SAPINA-BELTRAN, Esther
BENITEZ, Ivan D.
TORRES, Gerard
FORTUNA-GUTIERREZ, Ana M.
MARQUEZ, Paola Ponte
MASA, Juan F.
FELEZ, Miquel
VAZQUEZ, Susana
Citação
HYPERTENSION RESEARCH, v.45, n.3, p.436-444, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
High heterogeneity in the blood pressure (BP) response to continuous positive airway pressure (CPAP) exists in patients with resistant hypertension (RH). Only nondipper normotensive and hypertensive patients exhibited BP reductions when treated with CPAP; the baseline BP dipping pattern has been proposed as a predictor of BP response to CPAP but has never been explored in patients with RH. This study aimed to assess the effect of CPAP on BP in subjects with RH with respect to BP dipping pattern or nocturnal hypertension. This is an ancillary study of the SARAH study. RH subjects with an apnea/hypopnea index (AHI) >= 15/h and who received CPAP treatment for 1 year were included. Subjects underwent a sleep study and ambulatory BP monitoring (ABPM) at baseline and at the 1-year follow-up. Eighty-nine RH subjects were included. The subjects were mainly male (77.5%) and obese, with a mean age of 66 years (25th-75th percentile; 59.0; 70.0) and an AHI of 32.7/h (25th-75th percentile; 25.0; 54.7). A total of 68.5% of participants were nondippers, and 71.9% had nocturnal hypertension. After 1 year of CPAP, no significant differences in ABPM parameters were observed between dippers and nondippers. According to nighttime BP, subjects with nocturnal normotension did not show significant changes in ABPM parameters, while nocturnal hypertensive subjects achieved a significant reduction in mean nighttime BP of -4.38 mmHg (-7.10 to -1.66). The adjusted difference between groups was 3.04 (-2.25 to 8.34), which was not significant. This study shows that the BP response to CPAP in patients with RH does not differ according to the BP dipping pattern (dipper and nondipper) and suggests a differential response according to the presence of nocturnal hypertension.
Palavras-chave
Blood pressure, BP dipping pattern, Obstructive sleep apnea, Nocturnal hypertension, Resistant hypertension
URI
https://observatorio.fm.usp.br/handle/OPI/45849
Referências
  1. Ahmad M, 2017, INT J HYPERTENS, V2017, DOI 10.1155/2017/1848375
  2. Bratton DJ, 2014, THORAX, V69, P1128, DOI 10.1136/thoraxjnl-2013-204993
  3. Bunn A, 2020, INTRO DPLR, DOI [10.1016/ j.dendro.2008.01.002, DOI 10.1016/J.DENDRO.2008.01.002]
  4. Castro-Grattoni AL, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00651-2017
  5. Chiner E, 1999, Arch Bronconeumol, V35, P422
  6. Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
  7. Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a
  8. Fan HQ, 2010, J HYPERTENS, V28, P2036, DOI 10.1097/HJH.0b013e32833b49fe
  9. Fava C, 2014, CHEST, V145, P762, DOI 10.1378/chest.13-1115
  10. Hansen TW, 2011, HYPERTENSION, V57, P3, DOI 10.1161/HYPERTENSIONAHA.109.133900
  11. Hermida RC, 2020, EUR HEART J, V41, P4565, DOI 10.1093/eurheartj/ehz754
  12. Hermida RC, 2016, HYPERTENS RES, V39, P277, DOI 10.1038/hr.2015.142
  13. Hermida RC, 2010, AM J HYPERTENS, V23, P432, DOI 10.1038/ajh.2009.260
  14. Hermida RC, 2005, HYPERTENSION, V46, P1053, DOI 10.1161/01.HYP.0000172757.96281.bf
  15. Hou HF, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010405
  16. Iftikhar IH, 2014, J HYPERTENS, V32, P2341, DOI 10.1097/HJH.0000000000000372
  17. Javaheri S, 2017, J AM COLL CARDIOL, V69, P841, DOI 10.1016/j.jacc.2016.11.069
  18. Kasiakogias A, 2015, J HYPERTENS, V33, P393, DOI 10.1097/HJH.0000000000000371
  19. Levy P, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.15
  20. Liu LP, 2016, J CLIN HYPERTENS, V18, P153, DOI 10.1111/jch.12639
  21. Lloberes P, 2011, ARCH BRONCONEUMOL, V47, P143, DOI 10.1016/j.arbres.2011.01.001
  22. Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151
  23. Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7
  24. Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418
  25. Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250
  26. Masa JF, 2004, AM J RESP CRIT CARE, V170, P1218, DOI 10.1164/rccm.200312-1787OC
  27. Navarro-Soriano C, 2019, J HYPERTENS, V37, P1269, DOI 10.1097/HJH.0000000000002053
  28. Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017
  29. Pedrosa RP, 2013, CHEST, V144, P1487, DOI 10.1378/chest.13-0085
  30. Pedrosa RP, 2011, HYPERTENSION, V58, P811, DOI 10.1161/HYPERTENSIONAHA.111.179788
  31. Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901
  32. Sapina-Beltran E, 2019, ANN AM THORAC SOC, V16, P1414, DOI 10.1513/AnnalsATS.201901-053OC
  33. Sapina-Beltran E, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00098-2019
  34. Sapina-Beltran E, 2019, J HYPERTENS, V37, P720, DOI 10.1097/HJH.0000000000001934
  35. Sapina-Beltran E, 2018, ARCH BRONCONEUMOL, V54, P518, DOI 10.1016/j.arbres.2018.03.002
  36. Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X
  37. Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]
  38. Williams B, 2018, BLOOD PRESSURE, V27, P314, DOI [10.1097/HJH.0000000000001961, 10.1080/08037051.2018.1527177]

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/63
Artigos e Materiais de Revistas Científicas - ODS/03